Cargando…
Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
BACKGROUND: Mutations in the CHK2 gene at chromosome 22q12.1 have been reported in families with Li-Fraumeni syndrome. Chk2 is an effector kinase that is activated in response to DNA damage and is involved in cell-cycle pathways and p53 pathways. METHODS: We screened 139 breast tumors for loss of he...
Autores principales: | Ingvarsson, Sigurdur, Sigbjornsdottir, Bjarnveig I, Huiping, Chen, Hafsteinsdottir, Sigridur H, Ragnarsson, Gisli, Barkardottir, Rosa B, Arason, Adalgeir, Egilsson, Valgardur, Bergthorsson, Jon TH |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC111029/ https://www.ncbi.nlm.nih.gov/pubmed/12052256 |
Ejemplares similares
-
Alterations of E-cadherin and β-catenin in gastric cancer
por: Huiping, Chen, et al.
Publicado: (2001) -
Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
por: Gudmundsson, J., et al.
Publicado: (1995) -
The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
por: Arason, Adalgeir, et al.
Publicado: (2019) -
Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival
por: Ragnarsson, G, et al.
Publicado: (1999) -
The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients
por: Gudmundsdottir, Eydis Th, et al.
Publicado: (2012)